DOD FY11 Neurofibromatosis Clinical Trial Award

Post Date

May 3rd 2011

Application Due Date

September 15th 2011

Funding Opportunity Number

W81XWH-11-NFRP-CTA

CFDA Number(s)

12.420

Funding Instrument Type(s)

Cooperative Agreement
Grant

Funding Activity Categories

Science and Technology and other Research and Development

Number of Awards

2

Eligibility Categories

Unrestricted

Funding

• Estimated Total Funding:

  $2800000

• Award Range:

  $None - $None

Grant Description

The Neurofibromatosis Research Program (NFRP) was established in 1996 to promote the understanding, diagnosis, and treatment of neurofibromatosis (NF). The vision of the FY11 NFRP is to find and fund the best research to eradicate the clinical impact of NF. The NFRP Clinical Trial Award supports research with the potential to have a major impact on the treatment or management of NF or Schwannomatosis. Funding from this award mechanism must support a clinical trial and cannot be used for preclinical research studies. A clinical trial is defined as a prospective accrual of human subjects where an intervention (e.g., device, drug, biologic, surgical procedure, rehabilitative modality, behavioral intervention, or other) is tested on a human subject for a measurable outcome with respect to exploratory information, safety, effectiveness, and/or efficacy. This outcome represents a direct effect on the human subject of that intervention or interaction.

Contact Information

• Agency

  Department of Defense

• Office:

  Dept. of the Army -- USAMRAA

• Agency Contact:

  PA HELP and eReceipt HELP: 301-682-5507

• Agency Mailing Address:

  CDMRP Help Desk

• Agency Email Address:

  help@cdmrp.org